TCR2 Therapeutics Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for TCR2 Therapeutics Inc..The latest application filed is for "compositions and methods for tcr reprogramming using fusion proteins".

Company Profile

9.15.17

TCR2 Therapeutics Inc. - Cambridge MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Compositions And Methods For Tcr Reprogramming Using Fusion Proteins App 20220298478 - BAEUERLE; Patrick ; et al.	2022-09-22
Compositions and methods for TCR reprogramming using fusion proteins Grant 11,377,638 - Baeuerle , et al. July 5, 2	2022-07-05
Compositions and methods for TCR reprogramming using fusion proteins Grant 11,242,376 - Baeuerle , et al. February 8, 2	2022-02-08
Compositions And Methods For Tcr Reprogramming Using Fusion Proteins App 20210361704 - BAEUERLE; Patrick Alexander ; et al.	2021-11-25
Compositions And Methods For Tcr Reprogramming Using Target Specific Fusion Proteins App 20210315933 - Baeuerle; Patrick Alexander ; et al.	2021-10-14
Compositions And Methods For Tcr Reprogramming Using Fusion Proteins App 20210253666 - Baeuerle; Patrick Alexander ; et al.	2021-08-19
Compositions and methods for TCR reprogramming using fusion proteins Grant 11,085,021 - Baeuerle , et al. August 10, 2	2021-08-10
Compositions And Methods For Tcr Reprogramming Using Fusion Proteins App 20210206827 - BAEUERLE; Patrick ; et al.	2021-07-08
Engineered T Cells For The Treatment Of Cancer App 20210187022 - GETTS; Daniel ; et al.	2021-06-24
Compositions and methods for TCR reprogramming using fusion proteins Grant 11,028,142 - Baeuerle , et al. June 8, 2	2021-06-08
Compositions And Methods For Tcr Reprogramming Using Fusion Proteins App 20210079057 - BAEUERLE; Patrick ; et al.	2021-03-18
Compositions And Methods For Tcr Reprogramming Using Fusion Proteins App 20200362306 - BAEUERLE; Patrick ; et al.	2020-11-19
Compositions And Methods For Tcr Reprogramming Using Fusion Proteins App 20200362011 - BAEUERLE; Patrick ; et al.	2020-11-19
Compositions And Methods For Tcr Reprogramming Using Fusion Proteins App 20200207828 - BAEUERLE; Patrick ; et al.	2020-07-02
Compositions and methods for TCR reprogramming using fusion proteins Grant 10,442,849 - Baeuerle , et al. Oc	2019-10-15
Compositions And Methods For Tcr Reprogramming Using Fusion Proteins App 20190276540 - BAEUERLE; Patrick ; et al.	2019-09-12
Compositions And Methods For Tcr Reprogramming Using Fusion Proteins App 20190256571 - BAEUERLE; Patrick ; et al.	2019-08-22
Compositions and methods for TCR reprogramming using fusion proteins Grant 10,358,474 - Baeuerle , et al. July 23, 2	2019-07-23
Compositions and methods for TCR reprogramming using fusion proteins Grant 10,358,473 - Baeuerle , et al. July 23, 2	2019-07-23
Compositions And Methods For Tcr Reprogramming Using Fusion Proteins App 20190177694 - BAEUERLE; Patrick ; et al.	2019-06-13
Compositions and methods for TCR reprogramming using fusion proteins Grant 10,208,285 - Baeuerle , et al. Feb	2019-02-19
Compositions And Methods For Tcr Reprogramming Using Fusion Proteins App 20180251514 - BAEUERLE; Patrick ; et al.	2018-09-06
Compositions And Methods For Tcr Reprogramming Using Fusion Proteins App 20180244747 - BAEUERLE; Patrick ; et al.	2018-08-30
Compositions And Methods For Tcr Reprogramming Using Fusion Proteins App 20180230429 - BAEUERLE; Patrick ; et al.	2018-08-16
Compositions And Methods For Tcr Reprogramming Using Fusion Proteins App 20170166622 - BAEUERLE; Patrick ; et al.	2017-06-15

Company Registrations

SEC

0001750019

TCR2 THERAPEUTICS INC. of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.